GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NextGen Healthcare Inc (NAS:NXGN) » Definitions » PE Ratio

NextGen Healthcare (NextGen Healthcare) PE Ratio : At Loss (As of Apr. 26, 2024)


View and export this data going back to 1982. Start your Free Trial

What is NextGen Healthcare PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-04-26), NextGen Healthcare's share price is $23.94. NextGen Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.10. Therefore, NextGen Healthcare's PE Ratio for today is At Loss.

During the past 13 years, NextGen Healthcare's highest PE Ratio was 2011.00. The lowest was 0.00. And the median was 65.03.

NextGen Healthcare's EPS (Diluted) for the three months ended in Sep. 2023 was $0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.10.

As of today (2024-04-26), NextGen Healthcare's share price is $23.94. NextGen Healthcare's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was $0.75. Therefore, NextGen Healthcare's PE Ratio without NRI ratio for today is 32.13.

During the past 13 years, NextGen Healthcare's highest PE Ratio without NRI was 116.64. The lowest was 14.47. And the median was 35.06.

NextGen Healthcare's EPS without NRI for the three months ended in Sep. 2023 was $0.07. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was $0.75.

During the past 12 months, NextGen Healthcare's average EPS without NRI Growth Rate was 46.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -54.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was -27.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was -21.90% per year.

During the past 13 years, NextGen Healthcare's highest 3-Year average EPS without NRI Growth Rate was 140.20% per year. The lowest was -71.00% per year. And the median was 13.20% per year.

NextGen Healthcare's EPS (Basic) for the three months ended in Sep. 2023 was $0.08. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.09.

Back to Basics: PE Ratio


NextGen Healthcare PE Ratio Historical Data

The historical data trend for NextGen Healthcare's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextGen Healthcare PE Ratio Chart

NextGen Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.29 94.91 129.29 1,045.50 At Loss

NextGen Healthcare Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.10 53.66 At Loss 540.67 At Loss

Competitive Comparison of NextGen Healthcare's PE Ratio

For the Health Information Services subindustry, NextGen Healthcare's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NextGen Healthcare's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NextGen Healthcare's PE Ratio distribution charts can be found below:

* The bar in red indicates where NextGen Healthcare's PE Ratio falls into.



NextGen Healthcare PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

NextGen Healthcare's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=23.94/-0.100
=-239.4(At Loss)

NextGen Healthcare's Share Price of today is $23.94.
NextGen Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.10.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


NextGen Healthcare  (NAS:NXGN) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


NextGen Healthcare PE Ratio Related Terms

Thank you for viewing the detailed overview of NextGen Healthcare's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NextGen Healthcare (NextGen Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
3525 Piedmont Road, NE Building 6, Suite 700, Atlanta, GA, USA, 30305
NextGen Healthcare Inc is a United States-based company that provides healthcare solutions. The company offers technology and services platform supports for ambulatory and specialty practices of all sizes. It provides software, services, and analytics solutions to medical and dental group practices.
Executives
Three Prong Investments, Llc 10 percent owner 1695 VIKING RD, LAGUNA BEACH CA 92651
David A Metcalfe officer: Chief Technology Officer 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Mitchell Waters officer: EVP, Commercial Growth 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Craig A. Barbarosh director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
David Ahmadzai officer: Chief Accounting Officer 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Donna Cullen Greene officer: EVP, Human Resources 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Srinivas S Velamoor officer: EVP, Business Development 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
David William Sides officer: President and CEO 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Arnold James Robert Jr. officer: Chief Financial Officer 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Darnell Dent director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Pamela Puryear director 253 DOLPHIN COVE QUAY, STAMFORD CT 06902
Geraldine Mcginty director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Lonnie Allen Plunk officer: EVP, Operations 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
John R Frantz officer: CEO and President 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Lance Rosenzweig director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305